Clarity Pharmaceuticals Health Care

$0.700 0.005 (0.72%)

High $0.72	Low $0.70	Trades 33	Turnover $39,512	Volume 56,305
30 June 2023 at 4:10pm

Register to track CU6 and receive email alerts.

Market Cap (19-Sep) $827,996,160 (700th)	Close (30-Jun) $0.70 0 (0%)	Volume (30-Jun) 56,305	Shortsold (26-May) 28,715,960 (7.70%) (37th)
52w High $5.87	52w Low $1.97	P/E -	EPS -0.28

	Subject
	CU6 CU6 Article: Clarity Pharmaceuticals readies mega capital raising
	1 (current) 2 3
	CU6 CU6 Article: Three ASX companies jockeying to be the next biotech winners
	CU6 CU6 Article: Clarity Pharmaceuticals preps $110m raise; Bells, Wilsons mandated
	CU6 CU6 Ann: Cleansing Notice
	CU6 CU6 Ann: Application for quotation of securities - CU6
	CU6 CU6 Ann: Clarity Establishes US Center of Excellence for Research
	CU6 CU6 Ann: Northstar Achieves Key Production Milestones
	CU6 CU6 Ann: Cleansing Notice
	CU6 CU6 Ann: Application for quotation of securities - CU6
	CU6 CU6 Ann: COMBAT theranostic prostate cancer trial commences in the US
	CU6 CU6 Ann: Clarity expands supply of Cu-64 for Phase III trials
	CU6 CU6 Ann: Presentation at Jefferies Healthcare Conference
	CU6 CU6 Ann: Recruitment complete for Phase II prostate cancer trial
	CU6 CU6 Ann: Clarity to present at ASCO and SNMMI 2023 Annual Meetings
	CU6 CU6 Ann: Notification regarding unquoted securities - CU6
	CU6 CU6 Ann: Theranostic prostate cancer trial advances to cohort 2
	CU6 CU6 Ann: Final Director's Interest Notice - O'Bryan Tear
	CU6 CU6 Ann: Initial Director's Interest Notice
	CU6 CU6 Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	CU6 CU6 Ann: Clarity Receives $6.7 million R&D Tax Incentive Refund
	CU6 CU6 Ann: Notification of cessation of securities - CU6
	CU6 CU6 Ann: Notification regarding unquoted securities - CU6
	CU6 CU6 Ann: Clarity update on NorthStar copper-67 production
	CU6 CU6 Ann: Cleansing Notice
	CU6 CU6 Ann: Application for quotation of securities - CU6
	CU6 CU6 Ann: Clarity Corporate Presentation
	CU6 CU6 Ann: Clarity confirms no supply interruptions
	CU6 CU6 Ann: World leading expert in copper-67 joins Clarity SAB
	CU6 CU6 Ann: Half Yearly Report and Accounts
	CU6 CU6 Ann: Appendix 4D
	CU6 CU6 Ann: Change of Director's Interest Notice - Biggin
	CU6 CU6 Ann: Cleansing Notice
	CU6 CU6 Ann: Notification regarding unquoted securities - CU6
	CU6 CU6 Ann: Application for quotation of securities - CU6
	CU6 CU6 Ann: 50% recruitment milestone for NET diagnostic Phase II trial
	CU6 CU6 Ann: PROPELLER Trial Results
	CU6 CU6 Ann: Ceasing to be a substantial holder
	CU6 CU6 Article: GenesisCare drops Clarity Pharma stake, Wilsons on trade
	CU6 CU6 Ann: Diagnostic prostate cancer trial reaches recruitment target
	CU6 CU6 Ann: Application for quotation of securities - CU6
	CU6 CU6 Ann: Changes to Clarity Board of Directors
	CU6 CU6 Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	CU6 CU6 Ann: Notification regarding unquoted securities - CU6
	CU6 CU6 Ann: Positive topline results from SAR-bisPSMA diagnostic trial
	CU6 CU6 Ann: Cleansing Notice
	CU6 CU6 Ann: Application for quotation of securities - CU6
	CU6 CU6 Ann: Change of Director's Interest Notices - Taylor and Biggin
	CU6 CU6 Ann: Notification regarding unquoted securities - CU6
	CU6 CU6 Ann: Clarity Corporate Presentation & Webinar
	CU6 CU6 Ann: Clarity Corporate Presentation & Webinar

Register to track CU6 and receive email alerts.

End of Day Prices

Date	Close	Volume	Change
18-Sep	$3.53	1,598,701	+0.29 (8.95%)
12-Sep	$3.24	1,527,582	+0.11 (3.51%)
11-Sep	$3.13	1,661,390	-0.04 (1.26%)
05-Sep	$3.17	1,197,820	+0.04 (1.28%)
04-Sep	$3.13	1,687,219	+0.03 (0.97%)
03-Sep	$3.10	2,046,917	+0.12 (4.03%)
29-Aug	$2.98	4,850,945	-0.20 (6.29%)
28-Aug	$3.18	2,981,913	-0.21 (6.19%)
22-Aug	$3.39	2,593,743	-0.15 (4.24%)
21-Aug	$3.54	2,763,175	-0.12 (3.28%)
15-Aug	$3.66	1,744,649	+0.04 (1.10%)
14-Aug	$3.62	2,810,384	-0.76 (17.35%)
07-Aug	$4.38	4,185,588	+0.01 (0.23%)
31-Jul	$4.37	3,417,626	+0.04 (0.92%)
30-Jul	$4.33	2,723,736	0.00 (0.00%)
8 up, 6 down, and 1 flat days